Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2003
03/20/2003WO2003023012A2 Crystal structure of interleukin-22 and uses thereof
03/20/2003WO2003023010A2 Sensory neuron receptors
03/20/2003WO2003023008A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003WO2003023001A2 Novel proteins and nucleic acids encoding same
03/20/2003WO2003022999A2 Rapid detection of replicating cells
03/20/2003WO2003022995A2 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003WO2003022993A2 Methods for producing ex vivo models for inflammatory disease and uses thereof
03/20/2003WO2003022990A2 Production of fusion proteins and use for identifying binding molecules
03/20/2003WO2003022885A1 Chemokines
03/20/2003WO2003022882A2 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
03/20/2003WO2003022880A2 Synthetic hcv envelope proteins and their use for vaccination
03/20/2003WO2003022879A2 Peptides mimicking a cryptic epitope of gp41 hiv-1 and antibodies directed against them
03/20/2003WO2003022878A2 Subunit respiratory syncytial virus vaccine preparation
03/20/2003WO2003022877A1 Crystal structure of baff, and use thereof in drug design
03/20/2003WO2003022876A1 Food allergens, method of detecting food allergens and method of detecting food allergy-inducing foods
03/20/2003WO2003022866A1 LIGAND FOR ß2-GLYCOPROTEIN I AND USE THEREOF
03/20/2003WO2003022583A1 Acoustic ejection of fluids using large f-number focusing elements
03/20/2003WO2003022436A1 Method and device for isolating and/or determining an analyte
03/20/2003WO2003022435A2 Sample vessels
03/20/2003WO2003022421A2 Microcolumn-platform based array for high-throughput analysis
03/20/2003WO2003022299A1 Genobix agonists and antagonists for use in the treatment of metabolic disorders
03/20/2003WO2003022298A2 Use of a protein of the crmp family for treating diseases related to the immune system
03/20/2003WO2003022296A1 Method and composition for treating immune complex associated disorders
03/20/2003WO2003022223A2 Diagnosis and monitoring of systemic lupus erythematosus and of scleroderma
03/20/2003WO2003022126A2 Compositions and methods for the therapy and diagnosis of colon cancer
03/20/2003WO2003022042A1 Enhanced resolution of tumor metastasis
03/20/2003WO2003022028A2 Methods, reagents, kits and apparatus for protein function analysis
03/20/2003WO2003004677A3 Methods for generating differential profiles by combining data obtained in separate measurements
03/20/2003WO2003000848A3 Liver engrafting cells, assays, and uses thereof
03/20/2003WO2003000189A3 Prediction, diagnosis and treatment of endocrine resistant breast cancer, using p38 mapk pathway
03/20/2003WO2002103321A3 Methods of screening for ligands of target molecules
03/20/2003WO2002101367A3 Pipette-loaded bioassay assembly for detecting molecular or cellular events
03/20/2003WO2002101092A3 Oligonucleotides for detecting hybridisation
03/20/2003WO2002099075A3 Prmts as modifiers of the p53 pathway and methods of use
03/20/2003WO2002096364A3 Feline bronchioloalveolar lung carcinoma xenograft and cell line
03/20/2003WO2002091425A3 Fast variable gain detector system and method of controlling the same
03/20/2003WO2002088730A8 Biopolymer marker having a molecular weight of 1525 daltons
03/20/2003WO2002088324A3 Methods for determining secondary modifications of molecules using arrays
03/20/2003WO2002086468A8 Imaging apparatus and method
03/20/2003WO2002086086A3 Methods to identify agents that bind the flap-tip helix of rna polymerase
03/20/2003WO2002085285A3 Methods and reagents for regulating bone and cartilage formation
03/20/2003WO2002084252A3 Epitope-captured antibody display
03/20/2003WO2002083927A3 Universal multi-variant detection system
03/20/2003WO2002082092A3 Method for determining effective parathormone activity in a sample
03/20/2003WO2002082046A3 Silicon-wafer based devices and methods for analyzing biological material
03/20/2003WO2002079404A3 Cytoskeleton-associated proteins
03/20/2003WO2002077290A9 Methods for modifying pharmacokinetics and bioavailability of exogenous compounds
03/20/2003WO2002077194A3 Polymer synthesis
03/20/2003WO2002073157A3 Direct detection of biomolecules in polyacrylamide gel
03/20/2003WO2002071929A3 Methods of decreasing non-specific binding in dual bead assays and system apparatus for detecting medical targets
03/20/2003WO2002071074A3 Method for analyzing proteins
03/20/2003WO2002069908A3 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
03/20/2003WO2002068603A9 Materials and methods for the induction of premature chromosome condensation
03/20/2003WO2002064811A3 Method for producing recombinant proteins marked with at least one isotope
03/20/2003WO2002061047A3 Improved methods for protein identification, characterization and sequencing by tandem mass spectrometry
03/20/2003WO2002059602A8 A label-free high-throughput optical technique for detecting biomolecular interactions
03/20/2003WO2002055186A3 Surface modified semiconductive and metallic nanoparticlse having enhanced dispersibility in aqueous media
03/20/2003WO2002054045A3 Reagent for luminescence optical determination of an analyte
03/20/2003WO2002053733A3 Regulation of human b7-h2 protein
03/20/2003WO2002053728A3 Gene disruption methodologies for drug target discovery
03/20/2003WO2002053171A3 Use of intermediate-conductance potassium channels and modulators for the diagnosis and treatment of illnesses having disturbed keratinocyte activity
03/20/2003WO2002052269A3 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
03/20/2003WO2002050255A3 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof
03/20/2003WO2002046730A3 System and method for measuring the dielectric strength of a fluid
03/20/2003WO2002037102A3 Methods for analyzing dynamic changes in cellular informatics
03/20/2003WO2002036166A8 Compositions for stimulating cd45 and thereby suppressing microglial activation associated with alzheimer's disease
03/20/2003WO2002035205A3 Process for detecting or quantifying a biological reaction using superparamagnetic label
03/20/2003WO2002022809A9 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
03/20/2003WO2002022165A9 Non-genetic based protein disease markers
03/20/2003WO2002021138A3 The m30 gene family and the utilization thereof
03/20/2003WO2002020736A3 Proteases
03/20/2003WO2002020718A9 Osteoclast-associated receptor
03/20/2003WO2002020032A9 Stat3 agonists and antagonists and therapeutic uses thereof
03/20/2003WO2002018944A3 Means for diagnosing tumours
03/20/2003WO2002018635A3 Use of nonviable particles comprising an internal control (ic) nucleic acid
03/20/2003WO2002018620A3 Neutrokine-alpha and neutrokine-alpha splice variant
03/20/2003WO2002018445A9 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
03/20/2003WO2002014831B1 Inflatable mannequin and system for thermal property measurement and associated methods
03/20/2003WO2002014543A3 Process for detecting enzyme activity in an immunoassay
03/20/2003WO2002010707A9 System and method for monitoring water using bivalve mollusks
03/20/2003WO2002009641A9 Promyostatin peptides and methods of using same
03/20/2003WO2002004520A3 Transporters and ion channels
03/20/2003WO2002004490A3 Lipid metabolism molecules
03/20/2003WO2002002811A3 Method for controlling the microbiological quality of an aqueous medium and kit therefor
03/20/2003WO2001098535A3 Method for analyzing a nucleic acid
03/20/2003WO2001095233A3 Analysis of data from liquid chromatographic separation of dna
03/20/2003WO2001092579A3 Methods for detecting target nucleic acids using coupled ligation and amplification
03/20/2003WO2001090153A3 Reagents for cell selection and methods of use
03/20/2003WO2001088546A3 Treatments and markers for cancers of the central nervous system
03/20/2003WO2001085219A3 Identification, diagnosis, and treatment of breast cancer
03/20/2003WO2001079420A3 Detection and amplification or rna using target-mediated ligation of dna by rna ligase
03/20/2003WO1999049294A3 Assay methods
03/20/2003US20030056244 Feed additive compositions and methods
03/20/2003US20030056236 Model
03/20/2003US20030056234 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of myocardial infarction, atherosclerosis and cardiovascular disorders
03/20/2003US20030056233 Induction of psoriasis in animal model; obtain cells, transfer to transgenic rodent, administer cytokine, monitor development of skin disorder
03/20/2003US20030056232 Animal showing schizophrenia-like abnormality in cognitive behaviors and method of constructing the same
03/20/2003US20030056229 Nucleotide sequences coding polypeptide for use in the treatment of leukemias, autoimmune and arthritic diseases
03/20/2003US20030055341 Detection of cancer using cellular autofluorescence
03/20/2003US20030055326 Percutaneous biological fluid sampling and analyte measurement devices and methods
1 ... 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 ... 3937